Actavis’ Record-Breaking Quarterly Sales Show Success Of Merger Strategy
This article was originally published in The Pink Sheet Daily
Strong quarter for generic Mycardis, Lidoderm and Cymbalta spurs 36% increase in pharma product sales, while businesses inherited from Warner Chilcott lead to exponential growth in North American branded product revenue. Firm is getting ready for integration of Forest around mid-year.
You may also be interested in...
The traditionally generic-heavy company now has an expanded global presence and a growing branded business to go with its new name.
Two of the most prominent features of the House package are not addressed in the Senate measure, which predominantly focuses on cosmetics, dietary supplements and laboratory developed tests. The absence of competing proposals suggests a smooth conference process.
Decree imposes steps Abbott must complete before it can begin preparing to restart production, including hiring independent consultant to determine whether facility is compliant with FDA manufacturing and labeling regulations.